Literature DB >> 11467101

Marijuana in the management of amyotrophic lateral sclerosis.

G T Carter1, B S Rosen.   

Abstract

Marijuana has been proposed as treatment for a widening spectrum of medical conditions. Marijuana is a substance with many properties that may be applicable to the management of amyotrophic lateral sclerosis (ALS). These include analgesia, muscle relaxation, bronchodilation, saliva reduction, appetite stimulation, and sleep induction. In addition, marijuana has now been shown to have strong antioxidative and neuroprotective effects, which may prolong neuronal cell survival. In areas where it is legal to do so, marijuana should be considered in the pharmacological management of ALS. Further investigation into the usefulness of marijuana in this setting is warranted.

Entities:  

Mesh:

Year:  2001        PMID: 11467101     DOI: 10.1177/104990910101800411

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  11 in total

Review 1.  Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Authors:  Richard S Bedlack; Nanette Joyce; Gregory T Carter; Sabrina Paganoni; Chafic Karam
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

2.  Dosing medical marijuana: rational guidelines on trial in Washington State.

Authors:  Sunil K Aggarwal; Muraco Kyashna-Tocha; Gregory T Carter
Journal:  MedGenMed       Date:  2007-09-11

Review 3.  The endocannabinoid system as a target for the treatment of neurodegenerative disease.

Authors:  Emma L Scotter; Mary E Abood; Michelle Glass
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 4.  Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies.

Authors:  Vamsi Reddy; Dayton Grogan; Meenakshi Ahluwalia; Évila Lopes Salles; Pankaj Ahluwalia; Hesam Khodadadi; Katelyn Alverson; Andy Nguyen; Srikrishnan P Raju; Pankaj Gaur; Molly Braun; Fernando L Vale; Vincenzo Costigliola; Krishnan Dhandapani; Babak Baban; Kumar Vaibhav
Journal:  EPMA J       Date:  2020-04-15       Impact factor: 6.543

Review 5.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 6.  Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.

Authors:  Katherine A Belendiuk; Lisa L Baldini; Marcel O Bonn-Miller
Journal:  Addict Sci Clin Pract       Date:  2015-04-21

Review 7.  Pain in Neurodegenerative Disease: Current Knowledge and Future Perspectives.

Authors:  Marina de Tommaso; Lars Arendt-Nielsen; Ruth Defrin; Miriam Kunz; Gisele Pickering; Massimiliano Valeriani
Journal:  Behav Neurol       Date:  2016-06-05       Impact factor: 3.342

Review 8.  Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?

Authors:  Sabrina Giacoppo; Emanuela Mazzon
Journal:  Neural Regen Res       Date:  2016-12       Impact factor: 5.135

Review 9.  Cannabinoids in health and disease.

Authors:  Natalya M Kogan; Raphael Mechoulam
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

Review 10.  The endocannabinoid system: a putative role in neurodegenerative diseases.

Authors:  Giuseppe Di Iorio; Matteo Lupi; Fabiola Sarchione; Ilaria Matarazzo; Rita Santacroce; Filippo Petruccelli; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Int J High Risk Behav Addict       Date:  2013-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.